XSHE
300981
Market cap1.24bUSD
Oct 09, Last price
23.36CNY
1D
19.98%
1Q
131.52%
IPO
-57.17%
Name
Zhonghong Pulin Medical Products Co Ltd
Chart & performance
P/E
—
P/S
4.21
EPS
—
Div yield, %
1.28%
Shrs. gr., 5y
1.92%
Rev. gr., 5y
-13.53%
Revenues
2.37b
-3.40%
Net income
-112m
L+28.98%
CFO
4m
-97.97%
Dividend
May 27, 20260.35 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhonghong Pulin Medical Products Co., Ltd. is involved in the complete process of plastic glove production, from initial research and development to manufacturing and sales. The company's offerings specifically comprise disposable vinyl and nitrile gloves, which are designed for application in a variety of fields, including the healthcare sector, food handling, and electronics manufacturing. Established in 2010, the firm's main base of operations is located in Tangshan, China. It functions as a subsidiary under the corporate structure of Zhonghong Pulin Group Co., Ltd.
Related entities
Subsidiaries (2)
Jiangxi Zhonghong Pulin Medical Products Co.,Ltd
ZHPL GLOBAL HK LIMITED
Key people
Hao Yang
General Manager · since 2023
Mingang Li
Deputy General Manager · since 2023
Wei Deng
Secretary of the Board · since 2025
Linbo Zhang
Secretary of the Board · since 2021
Bin Jia
Staff Elected Director · since 2025
Shujun Sang
Chairman of the Board · since 2012
Yi Su
Director · since 2023
Yongling Yang
Director · since 2023
Zhidong Zhan
Director · since 2023
Director · since 2024
Zhuo Du
Independent Director · since 2024
Xudong Zhang
Independent Director · since 2022
Independent Director · since 2024
Headquarters & legal address
滦南县扒齿港工业园区
唐山市, HE 100000
CN
唐山市, HE 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||